These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 25013375)

  • 1. Recent advances in drug repositioning for the discovery of new anticancer drugs.
    Shim JS; Liu JO
    Int J Biol Sci; 2014; 10(7):654-63. PubMed ID: 25013375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug repositioning in cancer: The current situation in Japan.
    Masuda T; Tsuruda Y; Matsumoto Y; Uchida H; Nakayama KI; Mimori K
    Cancer Sci; 2020 Apr; 111(4):1039-1046. PubMed ID: 31957175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs.
    Bhattarai D; Singh S; Jang Y; Hyeon Han S; Lee K; Choi Y
    Curr Top Med Chem; 2016; 16(19):2156-68. PubMed ID: 26881715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational drug repositioning for cancer therapeutics.
    Jiao M; Liu G; Xue Y; Ding C
    Curr Top Med Chem; 2015; 15(8):767-75. PubMed ID: 25732789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing old drugs to fight multidrug resistant cancers.
    Dinić J; Efferth T; García-Sosa AT; Grahovac J; Padrón JM; Pajeva I; Rizzolio F; Saponara S; Spengler G; Tsakovska I
    Drug Resist Updat; 2020 Sep; 52():100713. PubMed ID: 32615525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational Drug Repurposing: Current Trends.
    Karaman B; Sippl W
    Curr Med Chem; 2019; 26(28):5389-5409. PubMed ID: 29848268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double Repositioning: Veterinary Antiparasitic to Human Anticancer.
    Sultana T; Jan U; Lee JI
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Drug Repurposing for Parkinson's Disease.
    Chen X; Gumina G; Virga KG
    Curr Med Chem; 2019; 26(28):5340-5362. PubMed ID: 30027839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico drug repositioning: what we need to know.
    Liu Z; Fang H; Reagan K; Xu X; Mendrick DL; Slikker W; Tong W
    Drug Discov Today; 2013 Feb; 18(3-4):110-5. PubMed ID: 22935104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in drug repurposing using machine learning.
    Urbina F; Puhl AC; Ekins S
    Curr Opin Chem Biol; 2021 Dec; 65():74-84. PubMed ID: 34274565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer Drug Discovery By Structure-Based Repositioning Approach.
    Modh DH; Kulkarni VM
    Mini Rev Med Chem; 2024; 24(1):60-91. PubMed ID: 37165589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposed itraconazole for use in the treatment of malignancies as a promising therapeutic strategy.
    Li CL; Fang ZX; Wu Z; Hou YY; Wu HT; Liu J
    Biomed Pharmacother; 2022 Oct; 154():113616. PubMed ID: 36055112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells.
    Veschi S; De Lellis L; Florio R; Lanuti P; Massucci A; Tinari N; De Tursi M; di Sebastiano P; Marchisio M; Natoli C; Cama A
    J Exp Clin Cancer Res; 2018 Sep; 37(1):236. PubMed ID: 30241558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems biology based drug repositioning for development of cancer therapy.
    Turanli B; Altay O; Borén J; Turkez H; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
    Semin Cancer Biol; 2021 Jan; 68():47-58. PubMed ID: 31568815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds.
    Würth R; Thellung S; Bajetto A; Mazzanti M; Florio T; Barbieri F
    Drug Discov Today; 2016 Jan; 21(1):190-199. PubMed ID: 26456577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach.
    Advani D; Gupta R; Tripathi R; Sharma S; Ambasta RK; Kumar P
    Neurochem Int; 2020 Nov; 140():104841. PubMed ID: 32853752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of current trends in computational drug repositioning.
    Li J; Zheng S; Chen B; Butte AJ; Swamidass SJ; Lu Z
    Brief Bioinform; 2016 Jan; 17(1):2-12. PubMed ID: 25832646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing antidepressants for anticancer drug discovery.
    Song Y; Yang X; Yu B
    Drug Discov Today; 2022 Jul; 27(7):1924-1935. PubMed ID: 34728374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting Non-Cancer Drugs for Cancer Therapy.
    Yang EJ; Wu C; Liu Y; Lv J; Sup Shim J
    Curr Top Med Chem; 2016; 16(19):2144-55. PubMed ID: 26881712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current state and outlook for drug repositioning anticipated in the field of ovarian cancer.
    Kobayashi Y; Banno K; Kunitomi H; Tominaga E; Aoki D
    J Gynecol Oncol; 2019 Jan; 30(1):e10. PubMed ID: 30479094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.